ClinicalTrials.gg
RecruitingNCT07933822Updated Nov 12, 2026

Therapy for Adverbial Clauses

An interventional study of Recast therapy in Developmental Language Disorder, sponsored by University of Arizona. Recruiting at 1 site in United States. Open to participants aged 5 Years to 7 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by University of Arizona · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jul 2026, registered Nov 2026).
  • Started Jul 2026; still recruiting 3 months later.
Updated Nov 12, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Not applicable
Ages
5 Years to 7 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 62 studies in Language Development Disorders with a site in United States — 25 open to participants now, 28 under way, none of them phase 3. Language Development Disorders · United States.

Planned enrollment
54th of 59
16 · median 80
Started
2026
with 8 others
No phase
54 of 62
22 open now
Primary completion
2028-07
later than 18 of 27 live
Registered
62nd of 62
by date
Lead sponsor
4 of 62
University of Arizona

Among the 62 studies in Language Development Disorders with a site in United States, this one is the 54th largest by planned enrollment of the 59 interventional ones that give a count, is one of 9 that started in 2026, is one of 54 with no phase, reaches primary completion later than 18 of the 27 other live ones, and was the 62nd registered.

Language Development Disorders

122 studies on the registry are indexed under Language Development Disorders; 50 are open to participants now.

Browse Language Development Disorders studies →

Open to participants now

25 of the 62 studies in Language Development Disorders with a site in United States are open now. Recruiting first, the newest first:

19 more — sign in →

All 25 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 35 Language Development Disorders studies recruiting now, 3 (9%) set no upper age limit and 32 (91%) stop at 75 or younger; 31 take children under 18; 20 take healthy volunteers.

This study: 5 Years to 7 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 62 studies in Language Development Disorders with a site in United States, or all of them as a file.
02

Study summary

The overall purpose of this project is to improve how 5 to 7 year old children who have trouble using language use complex sentences. The questions that this study is trying to answer are: Does this treatment help children use sentences with adverbial clauses (e.g., sentences with because, so that, when, until, etc.)? Do children maintain this learning over time?

Read the detailed description

This study will involve 5-7 year old children with Developmental Language Disorder. The study will teach complex sentences with adverbial clauses (e.g., sentences with conjunctions like because, so that, when, until, etc.). The study will involve an initial assessment of children's language skills. Children who qualify for the project will participate in 20 teletherapy treatment sessions across approximately 10 weeks. The treatment will involve listening to stories that include several sentences with adverbial clauses, and answering questions about the stories. Following the treatment, children will participate in post-treatment testing of their learning.

03

Conditions studied

  • Developmental Language Disorder

Keywords

  • Behavioral treatment
  • Language
  • Adverbs
04

Who can participate

Ages eligible
5 Years to 7 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between ages 5 years, 0 months and 7 years, 11 months at the time of treatment onset.
  • Have spoken English since birth, with exposure to other languages acceptable
  • Normal hearing as indicated by a word-repetition task
  • Normal nonverbal skills as indicated by the nonverbal scale of the Kaufman Brief Intelligence Test (score above 84)
  • Impaired language as indicated by the Structured Photographic Expressive Language Test (below cut score for age)
  • Regular use of spoken sentences (contains both a subject and predicate)
  • Poor performance (below 50% accuracy) on pretreatment syntax probes (Generating sentences based on pictures and short orally-presented scenarios)

Exclusion criteria

Exclusion Criteria:

  • Other developmental disabilities and handicapping conditions that could cause poor language skills (autism, intellectual disability, blindness, genetic disorders, neurologic disease or injury) by parent report, or significant speech-sound production disorder.
  • Native language skills other than English
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
16 participants (estimated)

Study arms

  • Experimental
    Treatment

    Behavioral treatment

    Behavioral: Recast therapy

Interventions

  • BehavioralRecast therapy

    Children will listen to examples of adverbial clauses in stories and generate sentences containing these clauses, then hear clinician recasts of their sentences

06

What researchers measure

Primary outcomes

  1. Sentence Generation Task

    Children will look at 14 pictures and generate sentences that go with those pictures.

    Time frame: Task is completed before each of 20 treatment sessions, starting with treatment session 1, over approximately 10 weeks.

  2. Sentence Repetition Task

    Children will repeat 10 sentences after the clinician.

    Time frame: At the end of the 10th week of treatment.

07

Study locations

1 of 1 sites recruiting
  • Department of Speech, Language & Hearing Sciences, University of Arizona
    Tucson, Arizona 85721, United States
    Recruiting
    • Melissa White, M.A. · Contactmelissacwhite@arizona.edu · 520-302-5641
    • Melissa White, M.A. · Principal investigator
    • Elena Plante, PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Jul 2028, 24 months after the start.

Of 73 non-industry interventional studies with no phase under Language Development Disorders, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 57. This study's planned 24 months is below that.

Counting every sponsor, half of 73 studies reached it within 30 months; a quarter within 19 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2026
First posted
Nov 12, 2026
StartActual
Jul 20, 2026
Primary completionEst.
Jul 20, 2028
CompletionEst.
Jul 20, 2028
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07933822
Responsible party
Elena Plante (Professor, University of Arizona) — Principal investigator
First posted
Nov 12, 2026
Start date
Jul 20, 2026
Primary completion
Jul 20, 2028 (estimated)
Completion
Jul 20, 2028 (estimated)
Last update
Nov 12, 2026

Study contacts

Melissa White, M.A.
Contact
melissacwhite@arizona.edu
520-302-5641
Elena Plante, PhD
study chair · University of Arizona

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion